CD8A and lymphoproliferative syndrome: Although initial reports referred to this as a lymphoproliferative disorder, the nomenclature was change to primary cutaneous acral CD8-positive T cell lymphoma in the 2017 revision of the 4th edition of the WHO classification [84].